Yale University scientists synthesize the aglycon of lomaiviticin A, a promising anticancer agent Feb. 16, 2011
Endpoint met in first part of phase II trial of Reolysin and gemcitabine in pancreatic cancer Feb. 15, 2011
Gold nanoshells with silica nanorattle cores combine photo- and chemotherapy to treat cancer Feb. 15, 2011
RSS